Waypoint Capital Advisors, LLC
- SEC CIK
- 0001905662
- Latest filing
- Oct 18, 2024
The latest 13F from Waypoint Capital Advisors, LLC covers Q3 2024 (filed Oct 18, 2024): 127 long positions worth $469.6M. The top 10 holdings make up 46.4% of the portfolio, and the largest is American Centy ETF Tr at 8.1%. Livermore has 12 filings on Form 13F from this institution, going back to Q4 2021.
What changed in Q3 2024
Share counts compared with Q2 2024: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 9
- Est. +$38.6M
- Added
- 53
- Est. +$31.6M
- Reduced
- 35
- Est. −$25.6M
- Sold out
- 3
- Est. −$1.26M
Top 5 holdings
Share of this quarter's portfolio value
- American Centy ETF Tr0250727038.1%$37.9M
- APGEApogee Therapeutics, Inc.
- Vanguard Morningstar Value ETF9229087445.7%$26.8M
- Vanguard Morningstar Growth ETF9229087365.1%$24.1M
- American Centy ETF Tr0250728854.7%$21.8M
Biggest buys
New and added positions, by estimated amount bought
- APGEApogee Therapeutics, Inc.
- American Centy ETF Tr025072158+$10.1MAdded
- Dimensional ETF Trust25434V732+$5.45MAdded
- Dimensional ETF Trust25434V203+$4.28MAdded
- American Centy ETF Tr025072125+$3.05MAdded
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- APGEApogee Therapeutics, Inc.
- American Centy ETF Tr025072158+2.00 pp1.4% → 3.4%
- Dimensional ETF Trust25434V732+1.01 pp1.5% → 2.5%
- Dimensional ETF Trust25434V203+0.87 pp0.5% → 1.3%
- American Centy ETF Tr025072125+0.63 pp0.3% → 0.9%
Biggest sells
Reduced and sold-out positions, by estimated amount sold
- American Centy ETF Tr025072703−$4.21MReduced
- American Centy ETF Tr025072885−$3.76MReduced
- American Centy ETF Tr025072604−$3.01MReduced
- American Centy ETF Tr025072877−$2.91MReduced
- American Centy ETF Tr025072349−$2.50MReduced
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
- American Centy ETF Tr025072703−1.70 pp9.8% → 8.1%
- American Centy ETF Tr025072885−1.41 pp6.1% → 4.7%
- American Centy ETF Tr025072604−1.06 pp4.2% → 3.2%
- American Centy ETF Tr025072877−0.85 pp2.6% → 1.7%
- American Centy ETF Tr025072349−0.80 pp2.5% → 1.7%
Metrics
13F metrics for Q3 2024, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $469.6M
- +$69.5M (+17.4%) vs. prior quarter
- Positions
- 127
- +6 vs. prior quarter
- Top 10 concentration
- 46.4%
- Top 10 as share of value
- Turnover
- 6.2%
- Q3 2024, one quarter
- Average holding period
- 9.2 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2021), so positions held before then are understated.
13F filings by quarter
12 quarters, going back to Q4 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $469.6M (Q3 2024)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q3 2024 | Oct 18, 2024 | 127 | $469.6M | American Centy ETF TrAPGEVanguard Morningstar Value ETF | vs. Q2 2024 | SEC |
| Q2 2024 | Jul 25, 2024 | 121 | $400.1M | American Centy ETF TrAmerican Centy ETF TrVanguard Morningstar Value ETF | vs. Q1 2024 | SEC |
| Q1 2024 | Apr 30, 2024 | 116 | $382.2M | American Centy ETF TrAmerican Centy ETF TrAmerican Centy ETF Tr | vs. Q4 2023 | SEC |
| Q4 2023 | Jan 22, 2024 | 117 | $343.8M | American Centy ETF TrAmerican Centy ETF TrAmerican Centy ETF Tr | vs. Q3 2023 | SEC |
| Q3 2023 | Oct 25, 2023 | 115 | $297.9M | American Centy ETF TrAmerican Centy ETF TrAmerican Centy ETF Tr | vs. Q2 2023 | SEC |
| Q2 2023 | Jul 13, 2023 | 132 | $320.4M | American Centy ETF TrAmerican Centy ETF TrAmerican Centy ETF Tr | vs. Q1 2023 | SEC |
| Q1 2023 | Apr 13, 2023 | 132 | $306.9M | American Centy ETF TrRXDXAmerican Centy ETF Tr | vs. Q4 2022 | SEC |
| Q4 2022 | Jan 23, 2023 | 129 | $288.5M | American Centy ETF TrRXDXAmerican Centy ETF Tr | vs. Q3 2022 | SEC |
| Q3 2022 | Oct 17, 2022 | 111 | $229.5M | American Centy ETF TrRXDXAmerican Centy ETF Tr | vs. Q2 2022 | SEC |
| Q2 2022 | Jul 18, 2022 | 111 | $220.3M | American Centy ETF TrSchwab U.S. Large-Cap Value ETFVanguard Ftse All-World Ex-US Index Fund | vs. Q1 2022 | SEC |
| Q1 2022 | Apr 19, 2022 | 119 | $170.1M | Vanguard Ftse All-World Ex-US Index FundGISAAPL | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 7, 2022 | 97 | $145.7M | Vanguard Ftse All-World Ex-US Index FundGISAAPL | – | SEC |